We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A number of EU countries have temporarily put AstraZeneca (AZ) vaccinations on hold after some patients given the shot formed blood clots, but the European Medicines Agency (EMA) said it has no reason to believe the vaccine is responsible. Read More
Nearly two months into the Biden administration, the president has still not nominated a permanent FDA commissioner or spoken publicly on who he’s considering, and a group of six former agency heads are imploring him to prioritize the task. Read More
Moderna has announced that it has begun dosing trial participants with a modified COVID-19 vaccine meant to target the variant SARS-Cov-2 strain first identified in South Africa. Read More
Fresh off the FDA’s March 1 authorization of Johnson & Johnson’s (J&J) single-shot vaccine, President Biden announced that the U.S. has secured an additional 100 million doses of the shot, doubling its original supply agreement with the company. Read More
House Democrats passed the $1.9 trillion COVID-19 relief bill yesterday in an 220-211 vote along party lines, sending the legislation to President Biden’s desk for signing on Thursday. Read More
EU member states increasingly frustrated with the speed of vaccine rollouts are going it alone through separate authorizations and side deals for vaccines from Russia and China. Read More
Eli Lilly said its combination antibody therapy, bamlanivimab and etesevimab, reduced the risk of hospitalization and death by 87 percent in a late-stage study of 769 high-risk COVID-19 patients — and worked against emerging variant strains of the coronavirus. Read More